Altered regulation of β-like globin genes by a redesigned erythroid transcription factor

Experimental Hematology

Volumn 35, Issue 1, 2007, Pages 39-47

  Manwani, Deepa ^a   Galdass, Mariann ^a   Bieker, James J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN; KRUPPEL LIKE FACTOR; ZINC FINGER PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DEVELOPMENT; EMBRYO; EMBRYONIC STEM CELL; ERYTHROLEUKEMIA CELL; GENE CONTROL; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENE SWITCHING; HEMOGLOBINOPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TRANSGENIC MOUSE;

ANIMALS; CELL LINE; EMBRYO; ERYTHROID CELLS; GENE EXPRESSION REGULATION; GENES, SWITCH; GLOBINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, TRANSGENIC; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; RESPONSE ELEMENTS; STEM CELLS; TRANSDUCTION, GENETIC; ZINC FINGERS;

MURINAE; MUS MUSCULUS;

EID: 33845750149     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2006.09.004     Document Type: Article

References (57)

1. Stamatoyannopoulos G.G. Hemoglobin switching. In: Stamatoyannopoulos G., Majerus P.W., Perlmutter R.M., and Varmus H. (Eds). The Molecular Basis of Blood Diseases (2001), W.B Saunders, Philadelphia
2. Behringer R.R., Ryan T.M., Palmiter R.D., Brinster R.L., and Townes T.M. Human gamma- to beta-globin gene switching in transgenic mice. Genes Dev 4 (1990) 380-389
3. Trimborn T., Gribnau J., Grosveld F., and Fraser P. Mechanisms of developmental control of transcription in the murine alpha- and beta-globin loci. Genes Dev 13 (1999) 112-124
4. Grosveld F., van Assendelft G.B., Greaves D.R., and Kollias G. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51 (1987) 975-985
5. Dillon N., and Grosveld F. Human gamma-globin genes silenced independently of other genes in the beta-globin locus. Nature 350 (1991) 252-254
6. Guy L.G., Mei Q., Perkins A.C., Orkin S.H., and Wall L. Erythroid Kruppel-like factor is essential for beta-globin gene expression even in absence of gene competition, but is not sufficient to induce the switch from gamma-globin to beta-globin gene expression. Blood 91 (1998) 2259-2263
7. Choi O.R., and Engel J.D. Developmental regulation of beta-globin gene switching. Cell 55 (1988) 17-26
8. Enver T., Raich N., Ebens A.J., Papayannopoulou T., Costantini F., and Stamatoyannopoulos G. Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice. Nature 344 (1990) 309-313
9. Hanscombe O., Whyatt D., Fraser P., et al. Importance of globin gene order for correct developmental expression. Genes Dev 5 (1991) 1387-1394
10. Peterson K.R., and Stamatoyannopoulos G. Role of gene order in developmental control of human gamma- and beta-globin gene expression. Mol Cell Biol 13 (1993) 4836-4843
11. Carter D., Chakalova L., Osborne C.S., Dai Y.F., and Fraser P. Long-range chromatin regulatory interactions in vivo. Nat Genet 32 (2002) 623-626
12. Patrinos G.P., de Krom M., de Boer E., et al. Multiple interactions between regulatory regions are required to stabilize an active chromatin hub. Genes Dev 18 (2004) 1495-1509
13. Palstra R.J., Tolhuis B., Splinter E., Nijmeijer R., Grosveld F., and de Laat W. The beta-globin nuclear compartment in development and erythroid differentiation. Nat Genet 35 (2003) 190-194
14. Tolhuis B., Palstra R.J., Splinter E., Grosveld F., and de Laat W. Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell 10 (2002) 1453-1465
15. Miller I.J., and Bieker J.J. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol 13 (1993) 2776-2786
16. Southwood C.M., Downs K.M., and Bieker J.J. Erythroid Kruppel-like factor exhibits an early and sequentially localized pattern of expression during mammalian erythroid ontogeny. Dev Dyn 206 (1996) 248-259
17. Bieker J.J., and Southwood C.M. The erythroid Kruppel-like factor transactivation domain is a critical component for cell-specific inducibility of a beta-globin promoter. Mol Cell Biol 15 (1995) 852-860
18. Nuez B., Michalovich D., Bygrave A., Ploemacher R., and Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature 375 (1995) 316-318
19. Perkins A.C., Sharpe A.H., and Orkin S.H. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature 375 (1995) 318-322
20. Donze D., Townes T.M., and Bieker J.J. Role of erythroid Kruppel-like factor in human gamma- to beta-globin gene switching. J Biol Chem 270 (1995) 1955-1959
21. Perkins A.C., Gaensler K.M., and Orkin S.H. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci U S A 93 (1996) 12267-12271
22. Wijgerde M., Gribnau J., Trimborn T., et al. The role of EKLF in human beta-globin gene competition. Genes Dev 10 (1996) 2894-2902
23. Drissen R., Palstra R.J., Gillemans N., et al. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev 18 (2004) 2485-2490
24. Gonzalez-Redondo J.M., Stoming T.A., Lanclos K.D., et al. Clinical and genetic heterogeneity in black patients with homozygous beta-thalassemia from the southeastern United States. Blood 72 (1988) 1007-1014
25. Rosatelli M.C., Oggiano L., Battista Leoni G., et al. Thalassemia intermedia resulting from a mild beta-thalassemia mutation. Blood 73 (1989) 601-605
26. Gilman J.G., Manca L., Frogheri L., et al. Mild beta+(-87)-thalassemia CACCC box mutation is associated with elevated fetal hemoglobin expression in cis. Am J Hematol 45 (1994) 265-267
27. Kulozik A.E., Bellan-Koch A., Bail S., Kohne E., and Kleihauer E. Thalassemia intermedia: moderate reduction of beta globin gene transcriptional activity by a novel mutation of the proximal CACCC promoter element. Blood 77 (1991) 2054-2058
28. Jaynes J.B., and O'Farrell P.H. Active repression of transcription by the engrailed homeodomain protein. EMBO J 10 (1991) 1427-1433
29. Han K., and Manley J.L. Functional domains of the Drosophila Engrailed protein. EMBO J 12 (1993) 2723-2733
30. Kadosh D., and Struhl K. Targeted recruitment of the Sin3-Rpd3 histone deacetylase complex generates a highly localized domain of repressed chromatin in vivo. Mol Cell Biol 18 (1998) 5121-5127
31. Laherty C.D., Yang W.M., Sun J.M., Davie J.R., Seto E., and Eisenman R.N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell 89 (1997) 349-356
32. Im H., Grass J.A., Johnson K.D., et al. Chromatin domain activation via GATA-1 utilization of a small subset of dispersed GATA motifs within a broad chromosomal region. Proc Natl Acad Sci U S A 102 (2005) 17065-17070
33. Feng W.C., Southwood C.M., and Bieker J.J. Analyses of beta-thalassemia mutant DNA interactions with erythroid Kruppel-like factor (EKLF), an erythroid cell-specific transcription factor. J Biol Chem 269 (1994) 1493-1500
34. Xue L., Chen X., Chang Y., and Bieker J.J. Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development. Blood 103 (2004) 4078-4083
35. Elnitski L., and Hardison R. Efficient and reliable transfection of mouse erythroleukemia cells using cationic lipids. Blood Cells Mol Dis 25 (1999) 299-304
36. Weiss M.J., Keller G., and Orkin S.H. Novel insights into erythroid development revealed through in vitro differentiation of GATA-1 embryonic stem cells. Genes Dev 8 (1994) 1184-1197
37. Kyba M., Perlingeiro R.C., and Daley G.Q. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 109 (2002) 29-37
38. Kennedy M., and Keller G.M. Hematopoietic commitment of ES cells in culture. Methods Enzymol 365 (2003) 39-59
39. Keller G., Webb S., and Kennedy M. Hematopoietic development of ES cells in culture. In: Klug C.A., and Jordan C.T. (Eds). Methods in Molecular Medicine (2003), Humana Press, Totowa, NJ Vol. 63. p. 209
40. Keller G., Kennedy M., Papayannopoulou T., and Wiles M.V. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol Cell Biol 13 (1993) 473-486
41. Sabatino D.E., Wong C., Cline A.P., et al. A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice. J Biol Chem 275 (2000) 28549-28554
42. Hogan B., Beddington R., Constantini F., and Lacy E. Manipulating the Mouse Embryo: A Laboratory Manual (1994), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
43. Migliaccio G., Migliaccio A.R., Kreider B.L., Rovera G., and Adamson J.W. Selection of lineage-restricted cell lines immortalized at different stages of hematopoietic differentiation from the murine cell line 32D. J Cell Biol 109 (1989) 833-841
44. Liu P.Q., Rebar E.J., Zhang L., et al. Regulation of an endogenous locus using a panel of designed zinc finger proteins targeted to accessible chromatin regions. Activation of vascular endothelial growth factor A. J Biol Chem 276 (2001) 11323-11334
45. Lim S.K., Bieker J.J., Lin C.S., and Costantini F. A shortened life span of EKLF-/- adult erythrocytes, due to a deficiency of beta-globin chains, is ameliorated by human gamma-globin chains. Blood 90 (1997) 1291-1299
46. Sabatino D.E., Seidel N.E., Aviles-Mendoza G.J., et al. Long-term expression of gamma-globin mRNA in mouse erythrocytes from retrovirus vectors containing the human gamma-globin gene fused to the ankyrin-1 promoter. Proc Natl Acad Sci U S A 97 (2000) 13294-13299
47. Blancafort P., Segal D.J., and Barbas III C.F. Designing transcription factor architectures for drug discovery. Mol Pharmacol 66 (2004) 1361-1371
48. Urnov F.D., Rebar E.J., Reik A., and Pandolfi P.P. Designed transcription factors as structural, functional and therapeutic probes of chromatin in vivo. Fourth in review series on chromatin dynamics. EMBO Rep 3 (2002) 610-615
49. Dhanasekaran M., Negi S., and Sugiura Y. Designer zinc finger proteins: tools for creating artificial DNA-binding functional proteins. Acc Chem Res 39 (2006) 45-52
50. Papworth M., Kolasinska P., and Minczuk M. Designer zinc-finger proteins and their applications. Gene 366 (2006) 27-38
51. Tan S., Guschin D., Davalos A., et al. Zinc-finger protein-targeted gene regulation: genomewide single-gene specificity. Proc Natl Acad Sci U S A 100 (2003) 11997-12002
52. Bartsevich V.V., Miller J.C., Case C.C., and Pabo C.O. Engineered zinc finger proteins for controlling stem cell fate. Stem Cells 21 (2003) 632-637
53. Jouvenot Y., Ginjala V., Zhang L., et al. Targeted regulation of imprinted genes by synthetic zinc-finger transcription factors. Gene Ther 10 (2003) 513-522
54. Urnov F.D., and Rebar E.J. Designed transcription factors as tools for therapeutics and functional genomics. Biochem Pharmacol 64 (2002) 919-923
55. Graslund T., Li X., Magnenat L., Popkov M., and Barbas III C.F. Exploring strategies for the design of artificial transcription factors: targeting sites proximal to known regulatory regions for the induction of gamma-globin expression and the treatment of sickle cell disease. J Biol Chem 280 (2005) 3707-3714
56. Rebar E.J., Huang Y., Hickey R., et al. Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med 8 (2002) 1427-1432
57. Camaschella C., Alfarano A., Gottardi E., Serra A., Revello D., and Saglio G. The homozygous state for the -87 C-G beta + thalassaemia. Br J Haematol 75 (1990) 132-133